SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Not Allowed)
NIH will soon offer funding for small businesses with recent SBIR/STTR Phase II/IIB awards to support technical assistance and late-stage R&D for commercialization, excluding clinical trials.
Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (Full application deadline, projected)
Funding Amounts: Not specified; typical award size varies by project and NIH institute.
Summary: Supports small businesses in the commercialization of SBIR/STTR Phase II and Phase IIB projects through additional technical assistance and late-stage R&D.
Key Information: Only U.S. small business concerns (SBCs) with recent or active SBIR/STTR Phase II/IIB awards are eligible.
Description
This program, administered by the National Institutes of Health (NIH), aims to accelerate the commercialization of products developed under SBIR and STTR Phase II and Phase IIB awards. The Commercialization Readiness Pilot (CRP) provides additional funding for technical assistance and late-stage research and development activities that are not typically supported through standard Phase II or IIB grants. Eligible activities may include independent replication of key studies, IND-enabling studies, clinical studies, manufacturing, regulatory assistance, or a combination of these services. The CRP is designed for small businesses that have received a qualifying NIH SBIR or STTR Phase II or IIB award within the last 36 months and are seeking to advance their innovations toward commercial markets.
